Locked contact intelligence
Contact Details & Ownership
Reveal verified contact points, shareholder visibility, and group structure signals beyond the public summary.
Contact DetailsShareholdersGroup StructureCorporate Network Graph
Back to search
Company profile
OXFORD TARGET THERAPEUTICS LIMITED
active • ltd • Bioinnovation Hub, Tonge Building Oxford Brookes University, Gipsy Lane, Headington Campus, Oxford, Oxfordshire, OX3 0BP, United Kingdom
Company no.13886983Officers4Documents0
Key company facts
Core operating details surfaced from the public profile endpoint.
- Company Number
- 13886983
- Company Status
- active
- Type
- ltd
- Date Of Creation
- 2022-02-02
- Registered Office
- Bioinnovation Hub, Tonge Building Oxford Brookes University, Gipsy Lane, Headington Campus, Oxford, Oxfordshire, OX3 0BP, United Kingdom
- Sic Codes
- research and experimental development on biotechnology
Financials
A cleaner view of the latest filing, balance sheet movement, and multi-year trend.
Total assets
£275,156
Equity
£196,094
Total liabilities
£79,062
Cash in bank
£62,399
Year-on-year movement
Quick comparison from the latest filed period.
2025-07-31
Equity
-£6.70k
-3.30%Cash in bank
+£6.12k
+10.87%Total assets
-£5.86k
-2.09%Total liabilities
-£837.00
-1.07%Financial trend
Multi-year view of the main balance sheet lines.
Net Assets
Total Assets
Total Liabilities
£281,016£86,507-£108,003
2022202320242025
Latest snapshot
Financial year2025
Statement date2025-07-31
Trade debtors£0
Trade creditors£0
Fixed assets£212,757
Current assets£62,399
| Year | Net Assets | Total Assets | Total Liabilities |
|---|---|---|---|
| 2022 | £0 | £0 | £0 |
| 2023 | £76,222 | £184,225 | -£108,003 |
| 2024 | £202,791 | £281,016 | -£78,225 |
| 2025 | £196,094 | £275,156 | -£79,062 |
Available In The Full Platform
Unlock deeper company intelligence
More company intelligence is available through your account, including premium data, deeper records, and advanced insight.
Locked compliance screening
Risk & Compliance
Access enhanced due diligence signals for KYC, sanctions, adverse media, phoenix risk, and register visibility.
KYC+Adverse Media ScreeningPhoenix Detection SummaryFCA Register
Locked financial insight
Financial Intelligence
Unlock premium financial analysis including credit insight, risk scoring, and AI-assisted valuation signals.
AI Financial Risk InsightsAI Company ValuationCredit ScoreCharges
Locked filing intelligence
Assets, Filings & Registers
Go beyond the headline profile with deeper asset, filing, register, and notice-level intelligence.
PropertyTrademarkGazette NoticesCharges
Latest activity
Recent company and officer updates, reshaped from the watchlist activity source for public profile use.
| Update | Date | Recency |
|---|---|---|
| Confirmation Statement Submitted | 19 May 2026 | 21 Days |
| Accounts Submitted | 18 Nov 2025 | 6 Months |
| Confirmation Statement Submitted | 17 May 2025 | 1 Year |
| Accounts Submitted | 15 Apr 2025 | 1 Year |
| KING, Linda Anne, Dr Appointed | 21 Feb 2025 | 1 Year |
| KING, Linda Anne, Prof Appointed | 21 Feb 2025 | 1 Year |
| CURTIS, Natalie Laura, Dr Resigned | 24 Oct 2024 | 1 Year |
| Accounts Submitted | 17 May 2024 | 2 Years |
| Confirmation Statement Submitted | 17 May 2024 | 2 Years |
| Change of Date Of Creation | 17 May 2024 | 2 Years |
| Change of Jurisdiction | 17 May 2024 | 2 Years |
| Change of Registered Office Address | 17 May 2024 | 2 Years |
Documents
Public filing documents and direct PDF links where available.
No records available.